Terms and Conditions
Last Updated: 08/20/2026
Acceptance of Terms
By accessing or using the services provided by PLEXUSDX, INC., you agree to be bound by these Terms and Conditions and our Privacy Policy.
If you do not agree to these terms, you should not use the Platform.
Telehealth Services
The Platform allows users to connect with licensed healthcare providers through telehealth consultations.
Healthcare providers using the Platform are independent medical professionals who are responsible for the medical care they provide.
Medical Advice Disclaimer
Information provided on the Platform is not intended to replace professional medical advice, diagnosis, or treatment.
Always consult with a qualified healthcare provider regarding medical concerns.
Eligibility
You must be at least 18 years old to use the Platform.
By using the Platform, you represent that you meet this requirement.
User Responsibilities
Users agree to:
- Provide accurate information
- Maintain the confidentiality of their account
-
Use the Platform only for lawful purposes
Prescription Policy
Healthcare providers may determine whether a prescription is appropriate based on a patient’s medical evaluation.
If prescribed, medications may be fulfilled by licensed pharmacies.
Payments
Users agree to pay all fees associated with services received through the Platform.
Payment processing may be handled by third-party payment processors.
Limitation of Liability
To the fullest extent permitted by law, PLEXUSDX, INC. shall not be liable for any indirect, incidental, or consequential damages arising from use of the Platform.
Modifications
We reserve the right to update these Terms at any time. Continued use of the Platform after changes are posted constitutes acceptance of the updated Terms.
Contact Information
PLEXUSDX, INC.
6110 McFarland Station Drive, #604
Alpharetta, GA 30004
info@plexusdx.com
877-760-2333
Important information
Compounded medications are not approved by the FDA or reviewed for quality, safety, or efficacy.
Novo Nordisk, Inc. is the only United States company with FDA-approved products containing semaglutide, identified under the trade names Rybelsus®, Ozempic®, and Wegovy®.
Lilly USA LLC is the only United States company with FDA-approved products containing tirzepatide, identified under the trade names Zepbound® and Mounjaro®.
The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.